Penumbra
PEN
#1783
Rank
NZ$15.74 B
Marketcap
$410.30
Share price
0.54%
Change (1 day)
7.89%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Earnings for Penumbra (PEN)

Earnings in 2024 (TTM): -NZ$4.85 Million

According to Penumbra's latest financial reports the company's current earnings are NZ$1.16 Billion. In 2023 the company made an earning of NZ$0.14 Billion, an increase over its 2022 earnings that were of NZ$10.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Penumbra from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$4.85 Million-103.4%
2023 NZ$0.14 B1272.57%
2022 NZ$10.37 M-181.08%
2021 -NZ$12.8 Million-80.74%
2020 -NZ$66.44 Million-181.97%
2019 NZ$81.05 M58.45%
2018 NZ$51.15 M2473.65%
2017 NZ$1.98 M-186.3%
2016 -NZ$2.31 Million-132.3%
2015 NZ$7.12 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$90.52 Million 7,901.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.30 B-26,724.13%๐Ÿ‡บ๐Ÿ‡ธ USA